Announced earlier this year,<\/a> the Denton facility is expected to create new U.S.-based Novartis jobs in bioengineering, advanced manufacturing, quality, and operations, supporting economic growth in Denton and surrounding communities, the company said.\u00a0<\/p>\nSwiss ambassador, U.S. Department of Commerce official took part in groundbreaking\u00a0<\/p>\n
Taking part in the groundbreaking in Denton were U.S. Under Secretary of Commerce for Industry and Security Jeffrey Kessler; Swiss Ambassador to the U.S. Ralf Heckner; Texas State Senator Brent Hagenbuch; Texas State Representative Andy Hopper; and Denton Mayor Gerard Hudspeth. They joined Novartis leadership, employees, and community partners to celebrate the start of construction.<\/p>\n
\u201cI\u2019m pleased to welcome Novartis to Denton as their newest manufacturing location for their cancer therapies,\u201d Texas State Senator Brent Hagenbuch said in a statement. \u201cTheir decision establishes a strong partnership and reflects the unique opportunity Denton provides to a well-educated workforce, and the unique access the new plant location will provide to the vibrant North Texas economy and rapidly growing state population.\u201d<\/p>\n
Producing medications for U.S. patients in the U.S.<\/p>\n
The Texas facility strengthens the Novartis coast-to-coast RLT manufacturing network, with existing US sites in New Jersey, Indiana and California, and another new site being added in Florida. Together, the facilities make up the largest U.S. RLT manufacturing network, further bolstering the company\u2019s longstanding track record of enabling over 99% of doses to be administered on the planned day of treatment.<\/p>\n
Each dose of RLT is custom-made and requires precise coordination, the company said, making manufacturing reliability and proximity to treatment centers key factors in providing timely treatment.<\/p>\n
At the groundbreaking, Kessler said the Trump Administration \u201cis delivering historic wins for the American people\u2014lowering drug prices, revitalizing manufacturing, creating jobs, and attracting massive new investments. Novartis\u2019s groundbreaking today is the latest example of the Administration\u2019s successful policies at work.<\/p>\n
In April 2025, Novartis said it was designating $23 billion over five years to grow its U.S. research and manufacturing footprint. Seven new and three expanded facilities across the country are already under construction\u2014part of the company\u2019s goal of manufacturing all key medicines for U.S. patients in the U.S, supporting supply resilience and dependable delivery of medicines.<\/p>\n
Don\u2019t miss what\u2019s next. Subscribe\u00a0to\u00a0Dallas\u00a0Innovates.<\/p>\n
Track Dallas-Fort Worth\u2019s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.<\/p>\n
\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Novartis breaks ground on its Denton radioligand therapy site. [Photo: Novartis] Swiss global pharmaceutical giant Novartis recently broke…\n","protected":false},"author":2,"featured_media":64387,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[35149,206,17633,8514,638,17,35150,9827],"class_list":{"0":"post-64386","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-switzerland","8":"tag-department-of-commerce-under-secretary-for-industry-and-security-jeffrey-kessler","9":"tag-novartis","10":"tag-pharmaceutical-manufacturing","11":"tag-radioligand-therapy","12":"tag-rlt","13":"tag-switzerland","14":"tag-texas-state-senator-brent-hagenbuch","15":"tag-vas-narasimhan"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116564196595950998","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/64386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=64386"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/64386\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/64387"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=64386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=64386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=64386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/05\/Novartis-breaks-ground-on-its-Denton-radioligand-therapy-site-Photo-Novartis.jpg\")
<\/p>\n